Related Experiment Video

Updated: Jul 15, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Pharmacological manipulation of cell death: clinical applications in sight?

Douglas R Green1, Guido Kroemer

  • 1Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. douglas.green@stjude.org.or

The Journal of Clinical Investigation
|October 4, 2005
PubMed

Insights

New therapies are emerging to correct cell death imbalances in human diseases. Research focuses on targeting apoptosis-related molecules for novel therapeutic strategies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Cell death, or apoptosis, plays a critical role in human health and disease.
  • Dysregulation of cell death pathways contributes to various pathological conditions.
  • Recent advancements have deepened our understanding of cell death mechanisms.

Purpose of the Study:

  • To explore the development of novel therapies for conditions involving excessive or deficient cell death.
  • To review current strategies targeting molecular pathways of cell death.
  • To highlight emerging drug candidates for therapeutic intervention.

Main Methods:

  • Elucidation of signal transduction pathways controlling cell death.
  • Identification of the molecular machinery responsible for cellular self-destruction.
  • Preclinical and clinical investigation of apoptosis-targeting compounds.

Main Results:

  • Significant progress in understanding cell death machinery over the past decade.
  • Development of novel strategies to modulate pathological cell loss or induce cell death.
  • Numerous compounds targeting apoptosis-related molecules are under investigation.

Conclusions:

  • The understanding of cell death mechanisms has paved the way for innovative therapeutic approaches.
  • A diverse array of drug candidates targeting key apoptosis regulators are in development.
  • These therapies hold promise for treating diseases characterized by cell death dysregulation.

More Related Videos

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology13:17

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

Published on: September 29, 2023

Quantification of Cytokine-Induced Cell Death in Human Colonic Organoids Using Live Fluorescence Microscopy10:03

Quantification of Cytokine-Induced Cell Death in Human Colonic Organoids Using Live Fluorescence Microscopy

Published on: August 2, 2024

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Cellular Injury IlI: Cellular Death01:11

Cellular Injury IlI: Cellular Death

Cell death is the irreversible loss of cellular structure and function, representing the final stage of severe injury. It plays a key role in both normal physiology and disease.Types of Cell DeathThe two main types are necrosis and apoptosis, though others like necroptosis and pyroptosis also exist.Necrosis:Necrosis is an unregulated form of cell death caused by severe injury such as trauma, toxins, or ischemia. It is characterized by cell swelling, membrane loss, rupture, and leakage of...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...